Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Dima

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
Journal of Hematology|November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World ExperienceCiprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Frontiers in Immunology|January 11, 2020
Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic LeukemiaDalma Deak, Cristina Pop, Alina-Andreea Zimta, et al.
Annals of Translational Medicine|February 8, 2021
A narrative review of central nervous system involvement in acute leukemiasDalma Deak, Nicolae Gorcea-Andronic, Valentina Sas, et al.
Critical Reviews in Clinical Laboratory Sciences|September 22, 2018
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndromeAncuta Jurj, Laura Pop, Bobe Petrushev, et al.
The Lancet. Haematology|February 10, 2025
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trialJorge E Cortes, Dong-Wook Kim, Tapan Saikia, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 2, 2020
MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily MembersValentina Sas, Sergiu Pasca, Ancuta Jurj, et al.
American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Genome Research|March 24, 2018
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA <i>CCAT2</i> induce myeloid malignancies via unique SNP-specific RNA mutationsMaitri Y Shah, Manuela Ferracin, Valentina Pileczki, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
Journal of Hematology|November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World ExperienceCiprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Frontiers in Immunology|January 11, 2020
Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic LeukemiaDalma Deak, Cristina Pop, Alina-Andreea Zimta, et al.
Annals of Translational Medicine|February 8, 2021
A narrative review of central nervous system involvement in acute leukemiasDalma Deak, Nicolae Gorcea-Andronic, Valentina Sas, et al.
Critical Reviews in Clinical Laboratory Sciences|September 22, 2018
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndromeAncuta Jurj, Laura Pop, Bobe Petrushev, et al.
The Lancet. Haematology|February 10, 2025
Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trialJorge E Cortes, Dong-Wook Kim, Tapan Saikia, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 2, 2020
MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily MembersValentina Sas, Sergiu Pasca, Ancuta Jurj, et al.
American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Genome Research|March 24, 2018
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA <i>CCAT2</i> induce myeloid malignancies via unique SNP-specific RNA mutationsMaitri Y Shah, Manuela Ferracin, Valentina Pileczki, et al.
Pageof 11